Literature DB >> 17050281

Genetic evaluation to establish the diagnosis of X-linked familial exudative vitreoretinopathy.

Kimberly A Drenser1, Wendy Dailey, Antonio Capone, Michael T Trese.   

Abstract

PURPOSE: To determine the usefulness of genetic analysis for confirming the diagnosis of X-linked familial exudative vitreoretinopathy (FEVR) and verifying the mode of inheritance.
METHODS: Twenty-seven consecutive patients diagnosed with FEVR were enrolled for genetic analysis. All patients underwent dilated fundus examination. A complete birth, medical, and family history was obtained at the time of examination. Patients were categorized by gender and family history in an effort to identify X-linked FEVR. Participants provided a blood sample for analysis and were evaluated for a mutation in the Norrie's disease gene (NDP) by direct sequencing.
RESULTS: Of the 27 enrolled patients, four male patients had a pedigree consistent with X-linked inheritance and 12 male patients had little or no family history. Two of these 16 patients were found to have a missense mutation in the NDP gene.
CONCLUSIONS: We found genetic testing of NDP to be helpful in confirming the diagnosis of X-linked FEVR in male patients, especially when limited family history was available. As genetic diagnostics improve, we feel that confirming diagnoses and informing patients better through genetic evaluation and consultation will become more useful in the clinical practice of ophthalmology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17050281     DOI: 10.1080/13816810600862402

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  1 in total

1.  Mutation spectrum of the Norrie disease pseudoglioma (NDP) gene in Indian patients with FEVR.

Authors:  Ganeswara Rao Musada; Subhadra Jalali; Anjli Hussain; Anupama Reddy Chururu; Pramod Reddy Gaddam; Subhabrata Chakrabarti; Inderjeet Kaur
Journal:  Mol Vis       Date:  2016-05-16       Impact factor: 2.367

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.